S
Sironax is a clinical-stage biotechnology company focused on developing targeted therapies for age-related degenerative diseases through advanced molecular biology techniques. The company aims to improve patient outcomes by addressing the underlying biological mechanisms that contribute to these conditions.
Updated 18 months ago
Funding
$200M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
YCFunding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Sironax is a clinical-stage biotechnology company focused on developing targeted therapies for age-related degenerative diseases through advanced molecular biology techniques. The company aims to improve patient outcomes by addressing the underlying biological mechanisms that contribute to these conditions.